
Cardiometabolic Medicine
The need for consistent updates and agile content is imperative for today’s clinician to remain current on the continuum of scientific data. In no therapeutic area is this more essential than in “Cardiometabolic Medicine,” a new term meant to encompass the interconnected and debilitating diagnoses of diabetes mellitus, heart failure, coronary artery disease/acute coronary syndrome, progressive renal insufficiency, and related disorders such as hypertension, hyperlipidemia, and hyperkalemia. These areas are subject to frequent pivotal trial publications, guidelines updates, FDA action, and outcomes assessments.
Our Tweetorials
Your new source for free CE/CME via Twitter!
Each program provides 0.5hr – 1.0hr credit for physicians, pharmacists, and nurses.
Surgical Considerations in Management of HCM
1b) Our distinguished faculty is Hartzell Schaff, MD, @HSchaffMD, Cardiovascular Surgeon @MayoClinic, and President, American Association for...
MRAs for potential renoprotection in CKD
1b) .@edgarvlermamd will be reviewing the mechanism of action #MOA of #mineralocorticoid receptor antagonists #MRAs in potential #renoprotection for...
The Patient Burden of PSVT and a Look at Contemporary and Emerging Abortive Management Options
2a) .@cpcannon & @md_pollack will be discussing patient #burden of #PSVT & take a look at current & #emerging abortive therapies. We see...
Multidimensional, Serial Risk Assessment in PAH: How, Why, and Then What to Individualize Goal-Directed Therapy
1b) @AlbertaPHdoc from #Edmonton will be discussing Multidimensional, Serial #RiskAssessment in #PAH: How, Why, and Then What to Individualize...
Individualized strategies to risk-stratify, manage, and educate patients with advancing CKD in the setting of T2D
2) This #tweetorial is supported by an unrestricted educational grant from Bayer and is intended for healthcare providers.— cardio-met...
HCM: The General Cardiology Perspective, Part 2
2) Our expert author is again Sergio Kaiser MD PhD FACC FESC 🇧🇷🇮🇱 @pabeda1, cardiologist 🫀, Professor 🎓 of #InternalMedicine, Rio de Janeiro State...
HCM: The General Cardiology Perspective, Part 1
2) Our expert author is Sergio Kaiser MD PhD FACC FESC 🇧🇷🇮🇱 @pabeda1, cardiologist 🫀, Professor 🎓 of #InternalMedicine, Rio de Janeiro State...
Journal Club: Real-World Adherence and Persistence to Direct Oral Anticoagulants in Patients With Atrial Fibrillation
1b) This is the third in a series; you can still earn 🆓CE/#CMEcredit for the first two tweetorials at https://t.co/mHOQVw4mlC and...
Q & A About HCM: Guidance from the Guidelines
2) Our expert author is JA Linderbaum MS, ARNP, FACC, FPCNA @jlinderbaum, Associate Professor of Medicine, @MayoClinic, CV #NursePractitioner,...
Multidisciplinary Management of the patient with T2D and CKD 3-4
2) This #accredited #tweetorial series on #kidneydisease #CKD is supported by an independent educational grant from the Boehringer Ingelheim/Lilly...
@Cardiomet_CE on Twitter
Your only source for ACCREDITED SoMe-delivered
serialized professional cardiometabolic education. Physicians, nurses, pharmacists–come one, come all!
On Twitter at @cardiomet_ce, we present a series of tweetorials, Twitter-delivered case studies, and Twitter Journal Clubs, each accredited for 0.5hr – 1.0hr CE/CME. Programs are presented by expert faculty in engaging and fully interactive format. Our unique program harnesses the reach, up-to-the-minute currency, and accessibility of social media to deliver a constant flow of accredited, interactive, expert-delivered educational programs to a multidisciplinary and interprofessional audience of engaged clinicians.